Navigation Links
NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
Date:4/24/2008

SAN MATEO, Calif., April 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present on Wednesday, April 30, 2008 at the Morgan Stanley Global Healthcare Unplugged Conference. Anthony DiTonno, President and Chief Executive Officer, will be presenting and Stephen Ghiglieri, Chief Financial Officer, will be available to respond to questions.

Event: 2008 Morgan Stanley Global Healthcare Unplugged Conference

Date: Wednesday, April 30, 2008

Time: 2:20 p.m. ET

Place: Ritz Carlton in Key Biscayne, Florida

An audio Web cast of the Company's presentations will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the company believes offers significant
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 The Formulate Fusion Fabric ... for sales and marketing teams looking for a fully-functional package ... kit as “everything you’ll need to put together a stunning ... comes with a number of displays and accessories that can ... feet by 20 feet in size. These components vary from ...
(Date:5/20/2013)... 20, 2013 , Collaboration ... Service (ARS) in treatment of mastitis ... Trials to begin in the second half 2013 ... company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) ... Agricultural Research Service (ARS) to develop and trial products ...
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... which has promised Milwaukee that it can provide citywide wireless ... by the Milwaukee Common Council after falling behind ... Midwest Fiber until June 7 to hook up the first ... company was to have the area hooked up by mid-January, ...
... voiced across the state that the recent U.S. Patent ... the patenting and licensing arm of the University of ... acknowledged leadership in stem cell research. , ,As one of ... overreaching patents on human embryonic stem cells held by the ...
... Is America rushing into the adoption of electronic medical ... data security? , ,The question has been raised on ... to provide incentives to encourage the adoption of interactive ... are construed as a barrier to the adoption of ...
Cached Biology Technology:Patent ruling doesn't tarnish Wisconsin's stem cell leadership 2Patent ruling doesn't tarnish Wisconsin's stem cell leadership 3Privacy, trust still the biggest barriers to electronic record sharing 2Privacy, trust still the biggest barriers to electronic record sharing 3
(Date:5/17/2013)... Why Tibetan antelope can live at elevations of ... research published in Nature Communications , investigators ... evidence that some genetic factors may be associated ... The data in this work will also provide ... biology of other ruminant species. , The Tibetan ...
(Date:5/16/2013)... a commitment to the support of underrepresented minority ... Foundation has announced the inaugural AGA Investing in ... by the National Institute of Diabetes and Digestive ... underrepresented minority students to further their research careers ... establishing this new award, AGA demonstrates its commitment ...
(Date:5/16/2013)... in neurodegenerative disease also plays a critical role in ... In a study of the common fruit fly, the ... responsible for sleeping and waking on a 24-hour rhythm. ... sleep-wake cycle is disturbed, making waking up on a ... discovery is particularly interesting because mutations in the human ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Gene involved in neurodegeneration keeps clock running 2
... global studies of future species shifts and losses foresees ... but offers new hope that it could be slowed ... experts Henrique Miguel Pereira and Paul Leadley, the 23-member ... DIVERSITAS, UNEP-WCMC and the secretariat of the CBD compared ...
... Spanish . , Scientists with the U.S. Department ... that,s always a hit at festive gatherings also is always ... a first-of-its-kind mathematical model that food processors and others can ... of salt and smoke compounds to reduce or eliminate microbial ...
... Asian-American youth are one of the fastest growing populations ... later in life, they are more likely to smoke ... or racial groups, according to the Department of Health ... is examining the unique differences in adolescent tobacco use ...
Cached Biology News:Continuing biodiversity loss predicted but could be slowed 2Continuing biodiversity loss predicted but could be slowed 3USDA scientists helping keep in-demand smoked salmon safe to eat 2School attendance, refusal skills combat smoking risk in youth 2
... provides a convenient and affordable alternative for ... with an eight-port disposable manifold, the StatMatic ... multi-channel pipettes. The eight-port manifold, designed for ... 100, 200, 250, or 300mL with well-to-well ...
... HRP Stabilizing Diluent (MOPS Buffered) has been ... Peroxidase conjugates in solution. HRP Stabilizer ... maintains the conformation of the antibody or ... Product is filtered at 0.2 microns., ,Contents: ...
384 Well PCR Plate Carrier for Thermo-Sealer...
... feature a dual strength adhesive system which facilitates ... The adhesives on either side of the frame ... to the glass has an easy release adhesive ... forms a stronger bond. This means that when ...
Biology Products: